CerS2 is a druggable target in triple-negative breast cancer.
CerS2 是三阴性乳腺癌的一个可药物靶点
期刊:
影响因子:
doi:10.1101/2025.08.15.670525
Alatawi Hissah, Nair Haritha H, Ai Lingbao, Mahmud Iqbal, Gour Abhishek, Singh Amandeep, Baek Doohyun, Yan Bowen, Maharjan Chandra K, Zhang Weizhou, Law Brian K, Zajac-Kaye Maria, Vulpe Christopher, Guryanova Olga A, Sharma Arun K, Garrett Timothy J, Sharma Abhisheak, Heldermon Coy D, Hong Sukwon, Narayan Satya
